Αναζήτηση | Griddixdog

σε πρόσθεσε στο άλλο

2026-06-11 19:02:27 -

Dasatinib Market Developments in Tyrosine Kinase Inhibitor Treatments

The global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....

0 Σχόλια 0 Μοιράστηκε 523 Views 0 Προεπισκόπηση